SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRobert Walters Regulatory News (RWA)

Share Price Information for Robert Walters (RWA)

Share Price is delayed by 15 minutes
Get Live Data
85.00    1.00 (1.19%)
Bid:
84.00
Ask:
89.20
Spread: 5.20 (6.19%)
Market Cap: £55.91m
RWA Live PriceLast checked at - London Stock Exchange

Intraday Robert Walters Share Chart

Director/PDMR Shareholding

15 Sep 2023 13:00

RNS Number : 6484M
Robert Walters PLC
15 September 2023
Β 

15 September 2023

ROBERT WALTERS PLC

(the "Company")

2023 PSP awards & Total Voting Rights

2023 PSP awards

The Company announces that, following his appointment as Chief Financial Officer of the Company, David Bower has been awarded options over 69,589 ordinary shares of 20 pence each in the capital of the Company ("Ordinary Shares") under the 2023 Robert Walters Performance Share Plan.

The awards, which were made in the form of options at nil cost, are subject to performance conditions which were described in further detail in the Company's 2022 annual report. Vesting will normally not occur before three years have elapsed.

Total Voting Rights

Robert Walters plc's issued share capital now consists of 76,517,770 Ordinary Shares, of which 4,074,000 Ordinary Shares are held in treasury.

Therefore, the total number of voting rights in Robert Walters plc is 72,443,770, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Robert Walters plc under the FCA's Disclosure Guidance and Transparency Rules.

Β 

Further information

Robert Walters plc

Toby Fowlston, Chief Executive

David Bower, Chief Financial Officer

Β 

+44 (0) 20 7379 3333

Williams Nicolson

Steffan Williams

Β 

+44 7767 345 563

www.robertwaltersgroup.com

Β 

Β 

APPENDIX

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

David Bower

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Robert Walters plc

(b)

LEI

213800LIE15BDEN3VW43

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of 20p each

(b)

Identification code of the Financial Instrument

ISIN Code : GB0008475088

(c)

Nature of the transaction

Grant of options over Ordinary Shares under the 2023 Robert Walters Performance Share Plan

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

0

69,589

(e)

Aggregated information

- Aggregated volume

- Price

Β 

69,589 (psp)

0

(f)

Date of the transaction

13 September 2023

(g)

Place of the transaction

Β Outside of trading venue (XOFF)

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFLFELATIELIV
Date   Source Headline
14th May 20269:24 amRNSDirector/PDMR Shareholding
13th May 202610:40 amRNSDirector/PDMR Shareholding
5th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSDirector/PDMR Shareholding
30th Apr 20263:16 pmRNSResult of AGM
30th Apr 202610:27 amRNSDirectorate change
28th Apr 202610:10 amRNSDirector/PDMR Shareholding
24th Apr 20269:34 amRNSDirector/PDMR Shareholding
17th Apr 20269:03 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSQ1 2026 Trading Update
14th Apr 20265:35 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Apr 20263:46 pmRNSHolding(s) in Company
1st Apr 20266:12 pmRNSAnnual Financial Report
30th Mar 20267:00 amRNSBoard and Management Changes
27th Mar 20262:56 pmRNSHolding(s) in Company
27th Mar 20262:54 pmRNSHolding(s) in Company
23rd Mar 20269:21 amRNSHolding(s) in Company
17th Mar 202610:00 amRNSHolding(s) in Company
11th Mar 20267:00 amRNS2025 Full-Year Results
3rd Feb 20264:08 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSQ4 2025 Trading Update
18th Dec 20257:00 amRNSAppointment of Non-Executive Director
18th Nov 20255:10 pmRNSHolding(s) in Company
17th Nov 20255:00 pmRNSHolding(s) in Company
6th Nov 20258:55 amRNSBLOCK LISTING SIX-MONTHLY RETURN
14th Oct 20257:00 amRNSQ3 2025 Trading Update
11th Sep 20253:06 pmRNSHolding(s) in Company
8th Aug 20252:33 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNS2025 Half-Year Results
23rd Jul 20254:56 pmRNSHolding(s) in Company
23rd Jul 20254:54 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSQ2 2025 Trading Update
9th Jun 20252:11 pmRNSHolding(s) in Company
4th Jun 20253:49 pmRNSHolding(s) in Company
2nd Jun 20252:50 pmRNSHolding(s) in Company
30th Apr 20254:09 pmRNSHolding(s) in Company
29th Apr 20252:59 pmRNSResult of 2025 Annual General Meeting
16th Apr 202512:06 pmRNSDirector/PDMR Shareholding
15th Apr 20257:00 amRNSQ1 2025 Trading Update
28th Mar 202511:00 amRNSAnnual Report and Annual General Meeting
12th Mar 202511:47 amRNSDirector/PDMR Shareholding
7th Mar 20259:28 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNS2024 full-year results
14th Feb 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSQ4 2024 Trading Update
10th Jan 20254:22 pmRNSHolding(s) in Company
17th Dec 20244:32 pmRNSHolding(s) in Company
13th Dec 202411:06 amRNSHolding(s) in Company
11th Dec 20247:00 amRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.